Australia: ACCC looking to undue health merger

Primary said the divestment represented about 3 per cent of its pathology collection centres and that the annual impact on profit would not be material.

Primary took over the centres and laboratories in February last year after peer Healthscope decided to close its Queensland pathology operations.

“As a result of Healthscope’s decision, Primary did not consider that the transaction would have the effect, or be likely to have the effect, of substantially lessening competition,” the company said in a release to the Australian Securities Exchange, adding that it continued to hold this view.

Primary said it would progressively divest the assets to Medlab Pathology over the course of 12 months to avoid “further loss of management time and the incurring of further costs associated with an on going ACCC investigation”.

The Australian Competition and Consumer Commission said the transaction “removed a significant third player in Queensland”, leaving just two major full-service pathology providers in that state.

ACCC chairman Rod Sims said Primary and Healthscope had completed the transaction without notifying the ACCC, “despite being on notice that the ACCC would have serious concerns about the likely competitive effect”.

Full Content: The Australian

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.